Fine Organic Industries
- Market Cap
- ₹16,828 Cr
- P/E
- 34.93
Key Fundamentals
SmallcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 21.50%
- Debt to Equity
- 0.06
- EPS (TTM)
- ₹157.11
- Book Value
- ₹955.64
- Market Cap
- ₹16,828 Cr
- P/E (TTM)
- 34.93
- P/B
- 5.74
- ROE
- 16.60%
- Dividend Yield
- 0.20%
- EBITDA
- ₹600 Cr
- 52W High
- ₹5,666.00
- 52W Low
- ₹3,856.00
- Day Range
- ₹5,407.00 – ₹5,522.50
- Volume
- 18,527
Peer Comparison
Commodities › Chemicals & Petrochemicals › Specialty Chemicals
| 1,620.00 | 61.46 | 1,64,897 | 14.71 | 1.41% | 23.90% | 31.00% | 16,142 | 2,718 | |
| 4,932.70 | 80.98 | 54,186 | 6.46 | 0.06% | 7.82% | 9.64% | 5,853 | 661 | |
| 10,077.00 | 56.75 | 51,687 | 11.58 | 0.08% | 19.80% | 21.00% | 4,066 | 910 | |
| 1,620.30 | 86.28 | 21,506 | 8.29 | 0.00% | 9.66% | 11.90% | 1,298 | 249 | |
| 1,531.20 | 19.66 | 20,885 | 3.23 | 0.48% | 9.82% | 11.40% | 9,749 | 1,063 | |
| 5,488.50 | 34.93 | 16,828 | 5.74 | 0.20% | 16.60% | 21.50% | 2,604 | 481 | |
| 449.50 | 27.49 | 16,299 | 2.60 | 0.22% | 7.17% | 6.86% | 10,579 | 593 | |
| Median 7 companies | 1,620.30 | 56.75 | 21,506 | 6.46 | 0.20% | 9.82% | 11.90% | 5,853 | 661 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 71
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 34
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 47
- Average
- Sales & profit trajectory 9% weight
- Financial Health
- 90
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 74
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 48
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 19.5%
No weaknesses listed
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 3 | 4 | 12 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 60.98
- Neutral
- MACD (12,26,9)
- 59.78
- Bullish
- SMA (50)
- 5,241.00
- Bullish
- SMA (200)
- 4,881.23
- Bullish
As of
Analyst Rating
9 of 11 analysts rate Buy, 0 Hold, 2 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +13.62% |
|---|---|
| 5Y | +15.87% |
| 3Y | −7.84% |
| 1Y | +4.28% |
| TTM | +12.73% |
Net profit
| 10Y | +18.56% |
|---|---|
| 5Y | +28.29% |
| 3Y | −12.29% |
| 1Y | +1.71% |
| TTM | +18.47% |
Operating cash flow
| 10Y | — |
|---|---|
| 5Y | +26.26% |
| 3Y | −3.93% |
| 1Y | +110.78% |
| TTM | — |
10Y: The statements do not go back far enough for this window.
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.83 pp |
|---|---|
| 5Y | +2.81 pp |
| 3Y | −7.13 pp |
| 1Y | −2.28 pp |
| TTM | +1.45 pp |
Revenue by year
| Mar 2017 | ₹778 Cr |
|---|---|
| Mar 2018 | ₹856 Cr |
| Mar 2019 | ₹1,060 Cr |
| Mar 2020 | ₹1,038 Cr |
| Mar 2021 | ₹1,133 Cr |
| Mar 2022 | ₹1,876 Cr |
| Mar 2023 | ₹3,023 Cr |
| Mar 2024 | ₹2,123 Cr |
| Mar 2025 | ₹2,269 Cr |
| Mar 2026 | ₹2,366 Cr |
Net profit by year
| Mar 2017 | ₹78.00 Cr |
|---|---|
| Mar 2018 | ₹95.00 Cr |
| Mar 2019 | ₹136 Cr |
| Mar 2020 | ₹165 Cr |
| Mar 2021 | ₹120 Cr |
| Mar 2022 | ₹260 Cr |
| Mar 2023 | ₹618 Cr |
| Mar 2024 | ₹412 Cr |
| Mar 2025 | ₹410 Cr |
| Mar 2026 | ₹417 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Fine Organic Industries Ltd trades at ₹5,299 as of 2026-11-17 with a market cap of ₹16,247 crore and a PE of 33.73x. The company is virtually debt-free with a debt-to-equity ratio of 0.03 and has delivered a 10-year compounded profit growth of 18%, though the 3-year profit CAGR of -13% signals a recent earnings contraction phase.
- Near-zero leverage with a debt-to-equity ratio of just 0.03, providing significant financial flexibility and resilience through commodity cycles.
- Strong long-term profitability track record with 10-year compounded profit growth of 18% and 10-year compounded sales growth of 14%, indicating durable competitive advantages in oleochemicals.
- Robust return on equity history with a 10-year average ROE of 25% and 5-year average ROE of 25%, well above the cost of equity for most Indian specialty chemical firms.
- TTM profit growth has recovered to 20% and TTM sales growth to 13%, suggesting the business is rebounding from the recent downturn in the 3-year compounded figures.
- ROCE stands at 20.07% as of 2026-11-17, reflecting efficient capital allocation and strong underlying business economics even after a period of margin pressure.
- The stock is trading 6.5% below its 52-week high of ₹5,666, indicating relative price stability and proximity to recent peaks.
- 5-year compounded profit growth of 28% and 5-year compounded sales growth of 16% demonstrate that the business scaled meaningfully over the medium term despite interim volatility.
- 1-year stock CAGR of 13% shows the market has begun re-rating the stock as earnings recovery becomes visible.
- 3-year compounded profit growth is -13% and 3-year compounded sales growth is -8%, indicating a significant earnings and revenue decline over the recent cycle.
- Price-to-book ratio of 5.54x is rich, implying the market is pricing in substantial future growth that may not materialise if oleochemical demand softens.
- Dividend yield of just 0.21% offers negligible income support, meaning investor returns are almost entirely dependent on capital appreciation.
- Last year ROE dropped to 17% from a 5-year average of 25%, signalling margin compression or capital efficiency deterioration that may persist.
- 3-year stock CAGR of only 7% and 5-year stock CAGR of 8% show muted long-term price returns relative to the broader Indian market indices over similar periods.
- As a specialty oleochemicals producer, the company is exposed to volatile palm oil and other fatty acid feedstock prices, which contributed to the recent 3-year profit decline of -13%.
- Market cap of ₹16,247 crore on TTM earnings implied by EPS of ₹157.11 means any deceleration in the current TTM profit growth of 20% could trigger a sharp de-rating from the 33.73x PE multiple.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Fine Organic delivered a strong Q2FY27 with 42% profit growth and 21% revenue expansion, reflecting healthy demand for oleochemical additives. The ₹120 crore additional investment in its SEZ subsidiary signals continued capacity build-out for exports. No material headwinds are visible in recent news flow. The trend is improving, and sustained volume growth alongside margin stability will be key to watch in coming quarters.
- Q2 profit surges 42% YoY Nov 02
Standalone net profit rose 42% YoY to ₹135.14 crore in Q2FY27, with revenue up 21% to ₹693.49 crore, signalling strong demand and margin expansion.
- ₹120 Cr SEZ subsidiary boost Nov 02
The board approved increasing investment in its SEZ subsidiary by ₹120 crore, indicating confidence in capacity expansion and export-oriented growth.
- Investor meet on Nov 26 Nov 17
Fine Organic will participate in an investor conference on November 26, 2026, with discussions based solely on publicly available information.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 540 | 488 | 547 | 550 | 596 | 517 | 607 | 588 | 597 | 555 | 625 | 694 | 729 |
| Expenses | 410 | 371 | 403 | 410 | 446 | 414 | 487 | 466 | 463 | 461 | 496 | 520 | 547 |
| Operating Profit | 130 | 117 | 144 | 139 | 150 | 103 | 120 | 123 | 134 | 94 | 129 | 174 | 182 |
| OPM % | 24% | 24% | 26% | 25% | 25% | 20% | 20% | 21% | 22% | 17% | 21% | 25% | 25% |
| Other Income | 17 | 17 | 22.83 | 24 | 22 | 25 | 26 | 47 | 21 | 21 | 35 | 24 | 30.64 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 1 | 2.11 |
| Depreciation | 14 | 15 | 15 | 12 | 12.41 | 13 | 15 | 12 | 13 | 14 | 18 | 14 | 14.43 |
| PBT | 133 | 119 | 150 | 152 | 160 | 115 | 130 | 157 | 143 | 101 | 144 | 184 | 197 |
| Tax % | 22% | 21% | 24% | 25% | 26% | 28% | 25% | 26% | 24% | 27% | 18% | 25% | 23% |
| Net Profit | 103 | 94 | 115 | 113 | 117 | 83 | 97 | 117 | 109 | 74 | 117 | 138 | 152 |
| EPS (₹) | 33.71 | 30.73 | 37.36 | 36.94 | 38.30 | 26.97 | 31.68 | 38.19 | 35.40 | 24.11 | 38.32 | 45.06 | 49.62 |
| YoY Sales growth | −41 | −36 | −8 | 0 | 10 | 6 | 11 | 7 | 0 | 7 | 3 | 18 | 22 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 (S) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 616 | 660 | 778 | 856 | 1,060 | 1,038 | 1,133 | 1,876 | 3,023 | 2,123 | 2,269 | 2,366 | 2,604 |
| Expenses | 500 | 514 | 633 | 697 | 827 | 803 | 935 | 1,513 | 2,194 | 1,591 | 1,757 | 1,886 | 2,024 |
| Operating Profit | 116 | 146 | 145 | 158 | 234 | 235 | 198 | 363 | 829 | 532 | 512 | 480 | 579 |
| OPM % | 19% | 22% | 19% | 19% | 22% | 23% | 17% | 19% | 27% | 25% | 23% | 20% | 22% |
| Other Income | 2 | 8 | 4 | 16 | 20 | 20 | 17 | 33 | 64 | 71.88 | 98 | 117 | 111 |
| Interest | 7 | 7 | 4 | 3 | 2 | 5 | 6 | 5 | 5 | 2 | 2 | 4 | 6 |
| Depreciation | 23 | 30 | 24 | 20 | 17 | 35 | 47 | 40 | 48 | 57 | 52 | 56 | 60 |
| Exceptional Items | — | — | — | — | — | — | — | — | — | −0.56 | — | 6.98 | — |
| PBT | 88 | 117 | 121 | 151 | 234 | 216 | 163 | 353 | 841 | 544 | 556 | 543 | 624 |
| Tax % | 33% | 35% | 36% | 37% | 40% | 24% | 26% | 26% | 26% | 24% | 26% | 23% | — |
| Net Profit | 59 | 76 | 78 | 95 | 136 | 165 | 120 | 260 | 618 | 412 | 410 | 417 | 482 |
| EPS (₹) | 19.27 | 24.85 | 25.40 | 31.09 | 44.43 | 53.74 | 39.24 | 84.67 | 201.60 | 134.34 | 133.89 | 136.03 | 157.11 |
| Div. Payout % | 25% | 29% | 9% | 23% | 16% | 13% | 28% | 11% | 4% | 7% | 8% | 8% | — |
| Sales growth | 9 | — | 18 | 10 | 24 | −2 | 9 | 66 | 61 | −30 | 7 | 4 | 13 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 (S) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 192 | 249 | 323 | 380 | 485 | 604 | 716 | 944 | 1,526 | 1,906 | 2,280 | 2,649 | 2,915 |
| Borrowings | 103 | 102 | 40 | 54 | 128 | 125 | 89 | 59 | 29 | 4 | 3 | 68 | 176 |
| Other Liabilities | 78 | 63 | 76 | 81 | 74 | 108 | 127 | 219 | 237 | 182 | 206 | 266 | 317 |
| Total Liabilities | 378 | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,504 | 2,999 | 3,423 |
| Fixed Assets | 124 | 125 | 97 | 88 | 78 | 217 | 196 | 229 | 214 | 268 | 363 | 388 | 438 |
| CWIP | 8 | 6 | 3 | 32 | 106 | 6 | 26 | 14 | 40 | 30 | 27 | 64 | 171 |
| Investments | 0 | 0 | 11 | 11 | 10 | 33 | 31 | 31 | 39 | 36 | 35 | 38 | 20 |
| Other Assets | 246 | 289 | 334 | 399 | 508 | 597 | 694 | 962 | 1,513 | 1,774 | 2,078 | 2,508 | 2,793 |
| Total Assets | 378 | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,504 | 2,999 | 3,423 |
Cash Flow
₹ Cr| Particulars | Mar 2015 (S) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | — | 45 | 65 | 98 | 219 | 134 | 67 | 485 | 635 | 204 | 430 |
| Investing | — | — | −16 | −52 | −93 | −85 | −40 | −32 | −128 | −396 | −675 | −430 |
| Financing | — | — | −55 | −17 | 92 | −37 | −41 | −68 | −69 | −59 | −35 | 0 |
| Net Cash Flow | — | — | −26 | −3 | 97 | 98 | 53 | −33 | 289 | 180 | −506 | −1 |
| Free Cash Flow | — | — | 34 | 13 | 5 | 146 | 88 | 6 | 405 | 549 | 77 | 288 |
| CFO/EBITDA | — | — | 65 | 73 | 79 | 119 | 89 | 41 | 86 | 148 | 68 | 116 |
Ratios
| Particulars | Mar 2015 (S) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 49 | 52 | 62 | 54 | 47 | 52 | 59 | 42 | 54 | 54 | 54 |
| Inventory Days | 59 | 72 | 68 | 58 | 50 | 79 | 63 | 72 | 91 | 78 | 100 | 104 |
| Days Payable | 51 | 50 | 47 | 46 | 30 | 51 | 49 | 47 | 36 | 41 | 43 | 45 |
| Cash Conversion Cycle | 64 | 71 | 72 | 75 | 74 | 74 | 66 | 84 | 97 | 91 | 111 | 113 |
| Working Capital Days | 49 | 80 | 69 | 80 | 76 | 63 | 65 | 79 | 76 | 77 | 104 | 92 |
| ROCE % | 33% | — | 35% | 38% | 44% | 32% | 22% | 39% | 65% | 31% | 26% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fine Organic Industries insights
63 extracted metrics across FY15–FY27.
Documents
- Q2 FY27 concall · Nov 2026PPT
- Q1 FY27 concall · Aug 2026PPT
- Concall · May 2026PPT
- Concall · Mar 2026Transcript
- Concall · Feb 2026PPT
- 19 May 2026
- 29 Sep 2025
- 16 Jul 2024
- 20 Jun 2023
- 18 Apr 2022
- 6 Apr 2021
- General announcements 17 Nov 2026
- General announcements 6 Nov 2026
- General announcements 3 Nov 2026
Frequently Asked Questions about Fine Organic Industries
What does Fine Organic Industries Ltd do?
Where is Fine Organic Industries Ltd (FINEORG) listed?
Which sector does Fine Organic Industries Ltd belong to?
What is the market capitalisation of Fine Organic Industries Ltd?
What is the PE ratio of Fine Organic Industries Ltd?
What is the 52-week high and low of Fine Organic Industries Ltd?
Does Fine Organic Industries Ltd pay dividends?
What is the Return on Equity (ROE) of Fine Organic Industries Ltd?
Company Information
Fine Organic Industries is engaged in and outside India as manufacturers, processors, suppliers, distributors, dealers, importers, exporters of wide range of oleochemical-based additives used in foods, plastics, cosmetics, coatings and other specialty application in various industries.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FINEORG.md for Fine Organic Industries Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.